Ther Drug Monit 2017 08;39(4):316-321
*Université François-Rabelais de Tours, CNRS, GICC UMR 7292, Tours, France; †Unit of Pharmacology-Toxicology, CHRU de Tours, Tours, France; ‡Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium; §Department of Biochemistry and Genetics, Université d'Angers, Angers, France; ¶Department of Immunology, CHRU de Tours, Tours, France; and ‖Biologicals Lab, Sanquin Diagnostic Services, Amsterdam, the Netherlands.